Legalization advocates have long speculated that “Big Pharma” is working behind the scenes to maintain cannabis prohibition. And in 2016, Insys Therapeutics, which makes products containing fentanyl and other opioids, as well as a synthetic version of the cannabinoid THC, donated half a million dollars to help defeat a marijuana legalization measure that appeared on Arizona’s ballot that year.
A prominent Democratic U.S. senator is slamming pharmaceutical companies for opposing marijuana legalization.
Democratic Senator of New York, Kirsten Gillibrand stated:
Big pharma keeps pushing back against legalizing medical marijuana because, in many cases, they want to continue to sell addictive drugs and dominate the market for drugs that address chronic pain. That's wrong.
It is time to rework our cannabis laws. https://t.co/g23trjnJcT
— Kirsten Gillibrand (@SenGillibrand) February 28, 2018